Search results

• 2018

  Repurposing tin mesoporphyrin as a novel immune checkpoint therapy in the treatment of cancer: A preclinical evaluation.

  Arnold, J. N., Muliaditan, T., Opzoomer, J. W., Caron, J., Okesola, M., Kosti, P., Lall, S., Van Hemelrijck, M., Dazzi, F., Tutt, A., Grigoriadis, A., Gillett, C., Madden, S. F., Burchell, J. M., Kordasti, S., Diebold, S. S. & Spicer, J. F., 20 May 2018, In: Journal of Clinical Oncology. 36, 15

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2017

  Immune-stroma-histological (ISH)-risk score identifies low-risk group within LN-positive breast cancers

  Grigoriadis, A., Gazinska, P., Pinder, S., Pai, T., Irshad, S., Wu, Y., Gillett, C. E., Tutt, A. N. & Coolen, A. C. C., 1 Oct 2017, In: Annals of oncology : official journal of the European Society for Medical Oncology. 28, p. vii27-vii28

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access